Currently, there are 633.00M common shares owned by the public and among those 582.82M shares have been available to trade.
Insiders at the company have transacted a total of 42 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 18 of these insider trades were purchases, accounting for 560,771 shares. Insider sales of the common stock occurred on 24 occasions, with total insider shares sold totaling 776,476 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of -3.75% and -20.34% over the past three months. MRO shares are trading -7.62% year to date (YTD), with the 12-month market performance down to -14.78% lower. It has a 12-month low price of $20.57 and touched a high of $29.56 over the same period. MRO has an average intraday trading volume of 9.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.58%, -6.77%, and -10.04% respectively.
Institutional ownership of Marathon Oil Corporation (NYSE: MRO) shares accounts for 78.48% of the company’s 633.00M shares outstanding.
It has a market capitalization of $13.06B and a beta (3y monthly) value of 2.22. The stock’s trailing 12-month PE ratio is 8.26, while the earnings-per-share (ttm) stands at $2.70. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.55% over the week and 2.22% over the month.
Analysts forecast that Marathon Oil Corporation (MRO) will achieve an EPS of $MorphoSys AG for the current quarter, $17.27 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Merck & Company, Inc. while analysts give the company a high EPS estimate of $Marathon Oil Corporation. Comparatively, EPS for the current quarter was $Frontline Plc a year ago. Earnings per share for the fiscal year are expected to decrease by -42.67%, and 8.19% over the next financial year.
Looking at the support for the MRO, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on December 11, 2023, with the firm’s price target at $27-$25.
